plerixafor has been researched along with tc14012 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baraz, R; Bendall, LJ; Bradstock, KF; Dela Pena, A; Juarez, JG; Thien, M | 1 |
| Berchiche, YA; Boulais, PE; Fujii, N; Gravel, S; Heveker, N; Leduc, R; Malouf, C; Oishi, S; Sinnett, D | 1 |
| Baraz, R; Bendall, LJ; Bradstock, KF; DiPersio, JF; Harun, N; Juarez, JG; Pena, AD; Pitson, SM; Rettig, M; Thien, M; Welschinger, R | 1 |
| Bach, HH; Byron, KL; Gamelli, RL; Majetschak, M; Nevins, AM; Tripathi, A; Volkman, BF; Wong, YM | 1 |
| Ge, B; He, H; Huang, F; Lao, J; Song, Y; Ullahkhan, N; Wang, X; Wang, Z; Yang, B | 1 |
5 other study(ies) available for plerixafor and tc14012
| Article | Year |
|---|---|
CXCR4 mediates the homing of B cell progenitor acute lymphoblastic leukaemia cells to the bone marrow via activation of p38MAPK.
Topics: Animals; B-Lymphocytes; Benzylamines; Bone Marrow; Cell Line, Tumor; Chemokine CXCL12; Chemotaxis, Leukocyte; Chromones; Cyclams; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Heterocyclic Compounds; Humans; Imidazoles; Mice; Mice, Inbred NOD; Mice, SCID; Morpholines; Neoplastic Stem Cells; Oligopeptides; p38 Mitogen-Activated Protein Kinases; Phosphoinositide-3 Kinase Inhibitors; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Binding; Receptors, CXCR4 | 2009 |
The peptidomimetic CXCR4 antagonist TC14012 recruits beta-arrestin to CXCR7: roles of receptor domains.
Topics: Anti-HIV Agents; Arrestins; Benzylamines; beta-Arrestins; Cell Line, Tumor; Chemokine CXCL12; Cyclams; Dose-Response Relationship, Drug; Enzyme Activation; HEK293 Cells; Heterocyclic Compounds; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Oligopeptides; Peptidomimetics; Protein Structure, Tertiary; Receptors, CXCR; Receptors, CXCR4; Recombinant Fusion Proteins | 2010 |
Sphingosine-1-phosphate facilitates trafficking of hematopoietic stem cells and their mobilization by CXCR4 antagonists in mice.
Topics: Adult; Aged; Animals; Anti-HIV Agents; Benzylamines; Blotting, Western; Cell Movement; Cell Proliferation; Cells, Cultured; Chemokine CXCL12; Cyclams; Cytokines; Drug Combinations; Drug Synergism; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Heterocyclic Compounds; Humans; Immunoenzyme Techniques; Lysophospholipids; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Knockout; Mice, SCID; Mice, Transgenic; Middle Aged; Oligopeptides; Phosphotransferases (Alcohol Group Acceptor); Prognosis; Real-Time Polymerase Chain Reaction; Receptors, CXCR4; Receptors, Lysosphingolipid; RNA, Messenger; Sphingosine; Sphingosine-1-Phosphate Receptors | 2012 |
Chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3 regulate vascular α₁-adrenergic receptor function.
Topics: Adrenergic Agonists; Animals; Benzylamines; Blood Pressure; Chemokine CXCL12; Cyclams; Heterocyclic Compounds; In Vitro Techniques; Ligands; Male; Mesenteric Arteries; Myocytes, Cardiac; Oligopeptides; Phenylephrine; Rats, Inbred Lew; Receptors, Adrenergic, alpha-1; Receptors, CXCR; Receptors, CXCR4; Shock, Hemorrhagic; Ubiquitin; Vasoconstriction; Ventricular Function, Left | 2014 |
Single-Molecule Imaging Demonstrates Ligand Regulation of the Oligomeric Status of CXCR4 in Living Cells.
Topics: Benzylamines; Cell Line, Transformed; Cell Line, Tumor; Chemokine CXCL12; Cyclams; Heterocyclic Compounds; Humans; Ligands; Microscopy, Fluorescence; Oligopeptides; Protein Multimerization; Receptors, CXCR4 | 2017 |